Literature DB >> 21915662

[WHO classification 2010 for the lower gastrointestinal tract: what is new?].

D E Aust1.   

Abstract

The new WHO classification of tumors of the digestive system not only redefines common diagnostic terms, such as intraepithelial neoplasia and dysplasia but also introduces changes in the nomenclature and diagnostics of colorectal tumors which will be important in daily practice. Changes in nomenclature and classification include the introduction of serrated adenocarcinoma, cribriform comedo type adenocarcinoma and micropapillary adenocarcinoma as new distinct histological subtypes of colorectal cancer. The grading of mucinous and signet ring carcinomas, which were previously invariably graded as G3/high grade, is now dependent on the microsatellite instability (MSI) status as a high MSI (MSI-H) indicates a better and low or no MSI (MSI-L/MSS) a worse prognosis. Thus, analysis of microsatellite instability via immunohistochemistry or fragment length analysis must be included in the pathological report of these tumors. Serrated polyps/adenomas and their potential of progression into colorectal cancer via the alternative pathway of colorectal carcinogenesis will be discussed as well as new insights into prognostic and predictive markers of colorectal cancer. This manuscript will give an overview of the most important changes within the new WHO classification of colorectal tumors.

Entities:  

Mesh:

Year:  2011        PMID: 21915662     DOI: 10.1007/s00292-011-1505-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  34 in total

1.  Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?

Authors:  Alessandro Inno; Mariantonietta Di Salvatore; Tonia Cenci; Maurizio Martini; Armando Orlandi; Antonia Strippoli; Anna Maria Ferrara; Cinzia Bagalà; Alessandra Cassano; Luigi Maria Larocca; Carlo Barone
Journal:  Clin Colorectal Cancer       Date:  2011-05-11       Impact factor: 4.481

Review 2.  Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

Authors:  Sergio Rizzo; Giuseppe Bronte; Daniele Fanale; Lidia Corsini; Nicola Silvestris; Daniele Santini; Gaspare Gulotta; Viviana Bazan; Nicola Gebbia; Fabio Fulfaro; Antonio Russo
Journal:  Cancer Treat Rev       Date:  2010-11       Impact factor: 12.111

3.  Primary invasive micropapillary carcinoma of the colon.

Authors:  K Sakamoto; M Watanabe; C De La Cruz; H Honda; H Ise; K Mitsui; K Namiki; Y Mikami; T Moriya; H Sasano
Journal:  Histopathology       Date:  2005-11       Impact factor: 5.087

Review 4.  Cancer in inflammatory bowel disease.

Authors:  Jianlin Xie; Steven H Itzkowitz
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

5.  Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.

Authors:  A Zaanan; P Cuilliere-Dartigues; A Guilloux; Y Parc; C Louvet; A de Gramont; E Tiret; S Dumont; B Gayet; P Validire; J-F Fléjou; A Duval; F Praz
Journal:  Ann Oncol       Date:  2009-10-15       Impact factor: 32.976

6.  Loss of heterozygosity and microsatellite instability in non-neoplastic mucosa from patients with chronic ulcerative colitis.

Authors: 
Journal:  Int J Mol Med       Date:  1998-08       Impact factor: 4.101

Review 7.  Diagnostic standards in the pathology of inflammatory bowel disease.

Authors:  Christoph Loddenkemper
Journal:  Dig Dis       Date:  2009-11-04       Impact factor: 2.404

8.  Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab.

Authors:  Andrea Sartore-Bianchi; Mauro Moroni; Silvio Veronese; Carlo Carnaghi; Emilio Bajetta; Gabriele Luppi; Alberto Sobrero; Carlo Barone; Stefano Cascinu; Giuseppe Colucci; Enrico Cortesi; Michele Nichelatti; Marcello Gambacorta; Salvatore Siena
Journal:  J Clin Oncol       Date:  2007-08-01       Impact factor: 44.544

9.  [Development of molecular-pathologic entities of colorectal cancer].

Authors:  T Kirchner; S Reu
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

10.  Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.

Authors:  Michael S Braun; Susan D Richman; Philip Quirke; Catherine Daly; Julian W Adlard; Faye Elliott; Jennifer H Barrett; Peter Selby; Angela M Meade; Richard J Stephens; Mahesh K B Parmar; Matthew T Seymour
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

View more
  8 in total

Review 1.  [Pathology of early stage cancer of the gastrointestinal tract : Definition, principles and diagnosis].

Authors:  B Märkl; B Martin
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

2.  Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy.

Authors:  Franck Housseau; Robert A Anders; Nicolas J Llosa; Brandon Luber; Nicholas Siegel; Anas H Awan; Teniola Oke; Qingfeng Zhu; Bjarne R Bartlett; Laveet K Aulakh; Elizabeth D Thompson; Elizabeth M Jaffee; Jennifer N Durham; Cynthia L Sears; Dung T Le; Luis A Diaz; Drew M Pardoll; Hao Wang
Journal:  Cancer Immunol Res       Date:  2019-08-22       Impact factor: 11.151

3.  Prognostic Value of LINC-ROR (rs1942347) Variant in Patients with Colon Cancer Harboring BRAF Mutation: A Propensity Score-Matched Analysis.

Authors:  Aly A M Shaalan; Sara H Mokhtar; Hanadi Talal Ahmedah; Amany I Almars; Eman A Toraih; Afaf T Ibrahiem; Manal S Fawzy; Mai A Salem
Journal:  Biomolecules       Date:  2022-04-12

4.  Expression and clinical significance of colorectal cancer stem cell marker EpCAMhigh/CD44+ in colorectal cancer.

Authors:  Dan Liu; Jinghua Sun; Jinming Zhu; Huan Zhou; Xian Zhang; Yang Zhang
Journal:  Oncol Lett       Date:  2014-02-21       Impact factor: 2.967

5.  Role of CT scan in differentiating the type of colorectal cancer.

Authors:  Zhen-Hui Li; Ding-Yun You; De-Pei Gao; Guang-Jun Yang; Xing-Xiang Dong; Da-Fu Zhang; Ying-Ying Ding
Journal:  Onco Targets Ther       Date:  2017-04-26       Impact factor: 4.147

6.  Palatine tonsil metastasis of cecal mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN): A unique case.

Authors:  Zoi Tsakiraki; Alexander Delides; Vasileia Damaskou; Sofia Psarogiorgou; Ilias Athanasiadis; Aris Spathis; Evangelos Giotakis; Ioannis G Panayiotides
Journal:  Clin Case Rep       Date:  2021-07-16

7.  Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis.

Authors:  Ulrich Nitsche; Anina Zimmermann; Christoph Späth; Tara Müller; Matthias Maak; Tibor Schuster; Julia Slotta-Huspenina; Samuel A Käser; Christoph W Michalski; Klaus-Peter Janssen; Helmut Friess; Robert Rosenberg; Franz G Bader
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

8.  Cribriform-type adenocarcinoma of the colorectum: comprehensive molecular analyses of a distinctive histologic subtype of colorectal cancer.

Authors:  Shun Yamada; Mitsumasa Osakabe; Makoto Eizuka; Mai Hashimoto; Noriyuki Uesugi; Naoki Yanagawa; Koki Otsuka; Hiromu Suzuki; Takayuki Matsumoto; Tamotsu Sugai
Journal:  Carcinogenesis       Date:  2022-06-27       Impact factor: 4.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.